NCT07147413Recruiting
Digital Health Platform Blood Pressure Management Study
Source: ClinicalTrials.gov · Last updated 15 Jul 2026
Brief summary (registry, in English)
This pilot study evaluated the effectiveness of an AI health education assistant compared to case manager support in hypertension management. Key outcomes included changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP), compliance with health behaviors, 722 goal achievement (monitoring, measurements, lifestyle improvements), and Technology Acceptance Model (TAM) metrics, including perceived usefulness (PU), perceived ease of use (PEU), and behavioral intention (BI). This study aims to examine whether the AI assistant group will achieve greater reductions in systolic and diastolic blood pressure compared to the case manager group. Additionally, it will evaluate whether the AI assistant group will demonstrate higher engagement in 722 goals and greater perceived ease of use. The results of this study are expected to provide further evidence supporting the potential of AI-driven interventions.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1726 (estimated)
- First submitted
- 21 Jul 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Diseases
- High blood pressure
- NCT number
- NCT07147413
What you commit to
- Study type: Interventional
- Planned participants: 1726
- From 1 Sept 2025 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive impairment or language barrier that prevents understanding of study procedures or informed consent
- Severe comorbidities that may interfere with study participation or outcomes (e.g., advanced heart failure, end-stage renal disease)
Other
- Participants will be excluded if they meet any of the following criteria:
- Systolic BP consistently \<120 mmHg and diastolic BP \<70 mmHg, based on baseline home monitoring (considered low BP not targeted in this study)
- Pregnant or planning to become pregnant during the study period
- Unable to operate a smartphone or digital device independently
- Current participation in another interventional clinical study that could conflict with this protocol
- Unwillingness to follow home blood pressure monitoring protocol or adhere to follow-up schedule
Who the study is looking for
- Participants must meet all of the following criteria:
- Aged 18 to 75 years at the time of enrollment
- Able and willing to provide informed consent
- Able to operate a mobile phone and interact with the digital platform
- Willing to participate in home blood pressure monitoring
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Taipei Veterans General Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.